As the Australian market shows signs of recovery with a significant 101-point surge, investors are optimistic about potential opportunities following positive developments in international relations. In this climate, identifying undervalued stocks becomes crucial as they offer the potential for growth amidst fluctuating market conditions and economic shifts. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) Titomic (ASX:TTT) A$0.225 A$0.42 46.6% SiteMinder (ASX:SDR) A$3.04 A$5.65 46.1% Nuix (ASX:NXL) A$1.315 A$2.47 46.7% Integral Diagnostics (ASX:IDX) A$2.32 A$4.53 48.8% Harmoney (ASX:HMY) A$0.775 A$1.44 46.1% Galan Lithium (ASX:GLN) A$0.405 A$0.75 46.2% Capricorn Metals (ASX:CMM) A$11.70 A$22.35 47.6% Betmakers Technology Group (ASX:BET) A$0.17 A$0.32 47.3% AML3D (ASX:AL3) A$0.21 A$0.39 46.2% Advanced Braking Technology (ASX:ABV) A$0.12 A$0.23 48.2% Click here to see the full list of 48 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Capricorn Metals Overview: Capricorn Metals Ltd, along with its subsidiaries, is engaged in the exploration, development, evaluation, and production of gold in Australia with a market capitalization of A$5.34 billion. Operations: Capricorn Metals generates revenue primarily from its Karlawinda gold operations, amounting to A$632.01 million. Estimated Discount To Fair Value: 47.6% Capricorn Metals appears undervalued, trading at A$11.7 against an estimated future cash flow value of A$22.35, suggesting a 47.6% discount to fair value. Recent earnings show significant profit growth, with net income rising to A$124.7 million from A$43.11 million year-over-year, driven by increased sales of A$327.48 million. The company also initiated its first dividend and forecasts robust revenue and earnings growth above market averages in the coming years. In light of our recent growth report, it seems possible that Capricorn Metals' financial performance will exceed current levels. Get an in-depth perspective on Capricorn Metals' balance sheet by reading our health report here.ASX:CMM Discounted Cash Flow as at Apr 2026 Galan Lithium Overview: Galan Lithium Limited focuses on the exploration, evaluation, and development of lithium properties and has a market cap of A$501.90 million. Operations: Galan Lithium Limited does not currently report any revenue segments in its financial statements. Estimated Discount To Fair Value: 46.2% Galan Lithium is trading at A$0.41, below its estimated future cash flow value of A$0.75, indicating a substantial discount. Despite recent shareholder dilution and a net loss of A$5.36 million for the half year ending December 2025, the company is forecast to achieve profitability within three years with expected revenue growth of 85.6% annually, significantly outpacing market averages. Recent inclusion in the S&P/ASX All Ordinaries Index may enhance investor visibility. Story Continues Our comprehensive growth report raises the possibility that Galan Lithium is poised for substantial financial growth. Dive into the specifics of Galan Lithium here with our thorough financial health report.ASX:GLN Discounted Cash Flow as at Apr 2026 PolyNovo Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices across several countries including Australia, New Zealand, the United States, and others, with a market cap of A$690.84 million. Operations: The company's revenue segment primarily consists of A$139.49 million from the development, manufacturing, and commercialization of the NovoSorb technology. Estimated Discount To Fair Value: 31.8% PolyNovo is trading at A$1, below its estimated future cash flow value of A$1.47, representing a 31.8% discount. Earnings are forecast to grow significantly at 37.2% annually over the next three years, outpacing the Australian market's growth rate of 11.9%. Despite a recent dip in net income to A$0.003 million for H1 2026, revenue increased to A$74.98 million from A$59.89 million year-on-year, indicating robust operational performance amidst executive board changes. Insights from our recent growth report point to a promising forecast for PolyNovo's business outlook. Unlock comprehensive insights into our analysis of PolyNovo stock in this financial health report.ASX:PNV Discounted Cash Flow as at Apr 2026 Make It Happen Unlock our comprehensive list of 48 Undervalued ASX Stocks Based On Cash Flows by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CMM ASX:GLN and ASX:PNV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX April 2026's Intrinsic Value Stock Picks For Savvy Investors
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...